Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Correlates of protection: novel generations of influenza vaccines.

Rimmelzwaan GF, McElhaney JE.

Vaccine. 2008 Sep 12;26 Suppl 4:D41-4. Review.

PMID:
19230158
2.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

PMID:
18948744
3.

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Cinatl J Jr, Michaelis M, Doerr HW.

Med Microbiol Immunol. 2007 Dec;196(4):213-25. Epub 2007 Jun 1. Review.

PMID:
17541633
4.

Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.

Hasegawa H, Ichinohe T, Tamura S, Kurata T.

Expert Rev Vaccines. 2007 Apr;6(2):193-201. Review.

PMID:
17408369
5.

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

Rimmelzwaan GF, Fouchier RA, Osterhaus AD.

Curr Opin Biotechnol. 2007 Dec;18(6):529-36. Review.

PMID:
18083548
6.

Influenza vaccines: the good, the bad, and the eggs.

Schultz-Cherry S, Jones JC.

Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Review.

PMID:
20951870
7.

Vaccines against epidemic and pandemic influenza.

Hoelscher M, Gangappa S, Zhong W, Jayashankar L, Sambhara S.

Expert Opin Drug Deliv. 2008 Oct;5(10):1139-57. doi: 10.1517/17425247.5.10.1139 . Review. Erratum in: Expert Opin Drug Deliv. 2009 Feb;6(2):209.

PMID:
18817518
8.

Current status and progress of prepandemic and pandemic influenza vaccine development.

Leroux-Roels I, Leroux-Roels G.

Expert Rev Vaccines. 2009 Apr;8(4):401-23. doi: 10.1586/erv.09.15. Review.

PMID:
19348557
9.

Animal models for the preclinical evaluation of candidate influenza vaccines.

Bodewes R, Rimmelzwaan GF, Osterhaus AD.

Expert Rev Vaccines. 2010 Jan;9(1):59-72. doi: 10.1586/erv.09.148. Review.

PMID:
20021306
10.

Vaccines to protect humans from pandemic avian influenza strains.

Campbell JD.

Md Med. 2006 Winter;7(1):15-8. Review.

PMID:
16613361
11.

Pre-pandemic and pandemic influenza vaccines.

Rockman S, Brown L.

Hum Vaccin. 2010 Oct;6(10):792-801. Epub 2010 Oct 1. Review.

PMID:
20935469
12.

The fight against new types of influenza virus.

Romanova J.

Biotechnol J. 2006 Dec;1(12):1381-92. Review.

PMID:
17124703
13.

Influenza vaccines and vaccination strategies in birds.

van den Berg T, Lambrecht B, Marché S, Steensels M, Van Borm S, Bublot M.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):121-65. Epub 2007 Sep 24. Review.

PMID:
17889937
14.

Progress with human H5N1 vaccines: a perspective from industry.

Palache B, Krause R.

Expert Rev Vaccines. 2009 Apr;8(4):391-400. doi: 10.1586/erv.09.16. Review.

PMID:
19348556
15.

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

Keitel WA, Atmar RL.

Curr Opin Pharmacol. 2007 Oct;7(5):484-90. Epub 2007 Jul 17. Review.

PMID:
17644429
16.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
17.

Vaccines in development against avian influenza.

Cox MM.

Minerva Med. 2007 Apr;98(2):145-53. Review.

PMID:
17519856
18.

Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.

Lynch GW, Selleck P, Church WB, Sullivan JS.

Immunol Cell Biol. 2012 Feb;90(2):149-58. doi: 10.1038/icb.2011.38. Epub 2011 Jun 7. Review.

PMID:
21647170
19.

Pandemic preparedness: toward a universal influenza vaccine.

Roose K, Fiers W, Saelens X.

Drug News Perspect. 2009 Mar;22(2):80-92. doi: 10.1358/dnp.2009.22.2.1334451. Review.

PMID:
19330167
20.

Development of vaccines against influenza A virus (H5N1).

Li WC, Huang YC.

Chang Gung Med J. 2007 Jul-Aug;30(4):294-304. Review.

Supplemental Content

Support Center